Resolution of extensive severe bronchiectasis in an infant.
Bronchiectasis is, by definition, an irreversible condition. Following recent reports of reversible bronchiectasis in children, it has been suggested that the definition be broadened to include pre-bronchiectasis and transitional reversible states. We describe the case of a young infant who had extensive, severe bronchiectasis of unknown etiology that resolved following prolonged treatment with antibiotics and a tapering course of oral steroids. We suggest that the prolonged treatment may have played a role, perhaps by eradicating infection and thus enabling regeneration of bronchial anatomy.
Crowley
Suzanne
S
Barneklinikken, Unit for Paediatric Heart, Lung, Allergic Diseases, Rikshospitalet, Oslo, Norway. suzanne.crowley@rikshospitalet.no
Matthews
Iren
I
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000628:therapy / Q000821:virology; D002442:Ceftazidime / Q000627:therapeutic use*; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D010102:Oxygen Inhalation Therapy; D011239:Prednisolone / Q000627:therapeutic use*; D011859:Radiography; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002442:Ceftazidime; D011239:Prednisolone